SALT LAKE CITY, Feb. 2, 2018 /PRNewswire/ — Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company developing a new class of Clean Surface Nanotherapeutic (CSNTM) drugs using an electro-crystal-chemistry drug development platform, announced today results from multiple…